Q1 2024 13F Holders as of 3/31/2024
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
67.6M
-
Number of holders
-
291
-
Total 13F shares, excl. options
-
74.1M
-
Shares change
-
+2.63M
-
Total reported value, excl. options
-
$2.62B
-
Value change
-
+$131M
-
Put/Call ratio
-
0.08
-
Number of buys
-
169
-
Number of sells
-
-105
-
Price
-
$35.41
Significant Holders of TANDEM DIABETES CARE INC - Common Stock, par value $0.001 per share (TNDM) as of Q1 2024
339 filings reported holding TNDM - TANDEM DIABETES CARE INC - Common Stock, par value $0.001 per share as of Q1 2024.
TANDEM DIABETES CARE INC - Common Stock, par value $0.001 per share (TNDM) has 291 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 74.1M shares
.
Largest 10 shareholders include BlackRock Inc. (9.23M shares), VANGUARD GROUP INC (7.05M shares), Capital World Investors (3.67M shares), MARSHALL WACE, LLP (3.12M shares), ArrowMark Colorado Holdings LLC (2.93M shares), JENNISON ASSOCIATES LLC (2.56M shares), STATE STREET CORP (2.24M shares), JANUS HENDERSON GROUP PLC (2.2M shares), Bellevue Group AG (2.03M shares), and Champlain Investment Partners, LLC (1.51M shares).
This table shows the top 291 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.